Publicaciones en las que colabora con MIGUEL ÁNGEL CALLEJA HERNÁNDEZ (8)

2013

  1. Pharmacogenetics and pharmacogenomics of chronic kidney disease comorbidities and kidney transplantation

    Omics for Personalized Medicine (Springer India), pp. 801-817

  2. Pharmacogenetics of opioid and alcohol addiction

    Omics for Personalized Medicine (Springer India), pp. 309-334

  3. Pharmacogenetics of oral anticoagulants

    Omics for Personalized Medicine (Springer India), pp. 435-467

2012

  1. Efecto del seguimiento farmacoterapéutico en pacientes con hiperparatiroidismo secundario tratados con cinacalcet

    Farmacia Hospitalaria, Vol. 36, Núm. 5, pp. 321-327

  2. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis

    OMICS A Journal of Integrative Biology, Vol. 16, Núm. 11, pp. 589-595

  3. Pharmacogenetics of osteoporosis: Towards novel theranostics for personalized medicine?

    OMICS A Journal of Integrative Biology, Vol. 16, Núm. 12, pp. 638-651

2011

  1. The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53- independent manner in colon and breast cancer cells

    PLoS ONE, Vol. 6, Núm. 8

2010

  1. Pharmacogenetics of osteoporosis-related bone fractures: Moving towards the harmonization and validation of polymorphism diagnostic tools

    Pharmacogenomics, Vol. 11, Núm. 9, pp. 1287-1303